Skip to content
10-Q

Quarterly Report

Apogee Therapeutics, Inc. APGE

0001193125-25-273260

← back to feed
Filed
Nov 10, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q3 2025 · Sep 30, 2025 58.77M sh
Shares Diluted Q3 2025 · Sep 30, 2025 58.47M sh
Shares Diluted Q3 2025 · Sep 30, 2024 56.8M sh
Shares Diluted Q3 2025 · Sep 30, 2024 54.51M sh
Shares Outstanding Q3 2025 · Sep 30, 2025 59.32M sh
Shares Outstanding Q3 2025 · Dec 31, 2024 58.06M sh
Capex Q3 2025 · Sep 30, 2025 $5.09M
Capex Q3 2025 · Sep 30, 2024 $1.15M
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$164.76M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$103.46M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $107.91M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $118.78M
Current Liabilities Q3 2025 · Sep 30, 2025 $34.05M
Current Liabilities Q3 2025 · Dec 31, 2024 $28.56M
Total Liabilities Q3 2025 · Sep 30, 2025 $39.82M
Total Liabilities Q3 2025 · Dec 31, 2024 $37.16M
Current Assets Q3 2025 · Sep 30, 2025 $540.1M
Current Assets Q3 2025 · Dec 31, 2024 $529.71M
Total Assets Q3 2025 · Sep 30, 2025 $626.16M
Total Assets Q3 2025 · Dec 31, 2024 $753.95M
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.11
Eps Diluted Q3 2025 · Sep 30, 2025 −$3.19
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.86
Eps Diluted Q3 2025 · Sep 30, 2024 −$2.11
Eps Basic Q3 2025 · Sep 30, 2025 −$1.11
Eps Basic Q3 2025 · Sep 30, 2025 −$3.19
Eps Basic Q3 2025 · Sep 30, 2024 −$0.86
Eps Basic Q3 2025 · Sep 30, 2024 −$2.11
Sga Expense Q3 2025 · Sep 30, 2025 $17.1M
Sga Expense Q3 2025 · Sep 30, 2025 $51.27M
Sga Expense Q3 2025 · Sep 30, 2024 $12.97M
Sga Expense Q3 2025 · Sep 30, 2024 $33.35M
Rd Expense Q3 2025 · Sep 30, 2025 $54.18M
Rd Expense Q3 2025 · Sep 30, 2025 $156.27M
Rd Expense Q3 2025 · Sep 30, 2024 $45.71M
Rd Expense Q3 2025 · Sep 30, 2024 $107.64M
Net Income Q3 2025 · Sep 30, 2025 −$65.02M
Net Income Q3 2025 · Sep 30, 2025 −$186.46M
Net Income Q3 2025 · Jun 30, 2025 −$66.1M
Net Income Q3 2025 · Mar 31, 2025 −$55.34M
Net Income Q3 2025 · Sep 30, 2024 −$49.02M
Net Income Q3 2025 · Sep 30, 2024 −$114.93M
Net Income Q3 2025 · Jun 30, 2024 −$33.82M
Net Income Q3 2025 · Mar 31, 2024 −$32.09M
Operating Income Q3 2025 · Sep 30, 2025 −$71.28M
Operating Income Q3 2025 · Sep 30, 2025 −$207.54M
Operating Income Q3 2025 · Sep 30, 2024 −$58.69M
Operating Income Q3 2025 · Sep 30, 2024 −$140.99M